The February issue of Arizona Attorney features another article I authored, Exploring the Psychedelic Frontier: The Terminally Ill and the Right to Try. In it, I explain psylocibin’s medical benefits and why Arizona’s Attorney General joined several states in appealing a Drug Enforcement Administration decision to deny terminally ill patients permission to use it.
Outlining how Right to Try allows patients and their doctors to sidestep regulations and avoid felony charges and how they qualify, I trace the historical and spiritual significance of psylocibin, as well as its medicinal properties with minimal adverse effects.
While it doesn’t cure the patient, psilocybin’s ability to lift depression and open neural pathways relieves the fear of death and gives patients greater dignity. Arizona, along with eight fellow amici, argued that the DEA has no business interfering with personal medical decisions by refusing to grant permission to use it — especially in “Hail Mary” scenarios that meet all Right to Try qualifications.
Read
